Gluco Pro Insulin Syringes Recalled

0
1160

The U.S.  Food and Drug Administration (FDA) just announced that Nipro Medical Corporation of Miami, Florida has issued a nationwide recall of all GlucoPro Insulin Syringes except for the GlucoPro syringe used specifically with the Amigo Insulin pump.

The needles could detach from the recalled syringes. If that happens, the needle can stick in the insulin vial, push back into the syringe, or remain in the skin after injection. Consumers who have GlucoPro Insulin Syringes should stop using them and return to point of sale for reimbursement.

This recall includes all product codes and lot numbers with expiration dates before 2011-11 (November 1, 2011):

• Product Code: JD+01U3008-5C; Lot Number: A08022; Expiry Date: 2011-11

• Product Code: JD+01U3013-5C; Lot Number: A08013; Expiry Date: 2011-06

• Product Code: JD+01U3013-5C; Lot Number: A08017; Expiry Date: 2011-08

• Product Code: JD+01U3108-5C; Lot Number: A08013; Expiry Date: 2011-06

• Product Code: JD+01U3108-5C; Lot Number: A08017; Expiry Date: 2011-08

• Product Code: JD+03U3008-5C; Lot Number: C08022; Expiry Date: 2011-11

• Product Code: JD+03U3013-5C; Lot Number: C08013; Expiry Date: 2011-06

• Product Code: JD+03U3013-5C; Lot Number: C08017; Expiry Date: 2011-08

• Product Code: JD+03U3108-5C; Lot Number: C08013; Expiry Date: 2011-06

• Product Code: JD+03U3108-5C; Lot Number: C08017; Expiry Date: 2011-08

• Product Code: JD+05U3008-5C; Lot Number: B08022; Expiry Date: 2011-11

• Product Code: JD+05U3013-5C; Lot Number: B08013; Expiry Date: 2011-06

• Product Code: JD+05U3013-5C; Lot Number: B08017; Expiry Date: 2011-08

• Product Code: JD+05U3108-5C; Lot Number: B08013; Expiry Date: 2011-06

• Product Code: JD+05U3108-5C; Lot Number: B08017; Expiry Date: 2011-08

Nipro Medical voluntarily recalled the products after learning of possible needle detachment; the FDA is aware of this action. To date, no injuries have been reported. The recalled GlucoPro Insulin Syringes were distributed nationwide, including Puerto Rico.

Nipro Medical is notifying its distributors and customers by fax and email and is arranging for return of all recalled products. Consumers with questions may contact the company at 1-305-599-7174 x249.

Adverse reactions or quality problems experienced with the use of this product can be reported to the FDA’s MedWatch Adverse Event Reporting program either online at www.fda.gov/medwatch/report.htm; by fax to 1-800-FDA-0178; or by regular mail using postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm that is then mailed to MedWatch/5600 Fishers Lane/Rockville/Maryland/20852-9787.